SUPRIYA LIFESCIENCE
Back to Cashflow Statement
|
SUPRIYA LIFESCIENCE Last 5 Year Cash Flow from Financing Activities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-8.23 Cr | ₹-22 Cr | ₹-10 Cr | ₹150 Cr | ₹-15 Cr |
What is the latest Cash Flow from Financing Activities ratio of SUPRIYA LIFESCIENCE ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-8.23 Cr |
| Mar2024 | ₹-22 Cr |
| Mar2023 | ₹-10 Cr |
| Mar2022 | ₹150 Cr |
| Mar2021 | ₹-15 Cr |
How is Cash Flow from Financing Activities of SUPRIYA LIFESCIENCE Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-8.23 Cr | Negative | |
| Mar2024 | ₹-22 Cr | Negative | |
| Mar2023 | ₹-10 Cr | Negative | |
| Mar2022 | ₹150 Cr | Positive | |
| Mar2021 | ₹-15 Cr | - | |
Compare Cash Flow from Financing Activities of peers of SUPRIYA LIFESCIENCE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUPRIYA LIFESCIENCE | ₹5,556.9 Cr | -5.7% | -9.6% | -1.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹413,717.0 Cr | 0.4% | 2.6% | NA | Stock Analytics | |
| DIVIS LABORATORIES | ₹166,830.0 Cr | -4.5% | 0.7% | 3.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹142,479.0 Cr | 5% | 4.1% | 37.2% | Stock Analytics | |
| CIPLA | ₹108,978.0 Cr | -0.5% | -3.4% | -6.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,905.0 Cr | 1.2% | 10.2% | 4.8% | Stock Analytics | |
SUPRIYA LIFESCIENCE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUPRIYA LIFESCIENCE | -5.7% |
-9.6% |
-1.4% |
| SENSEX | -0.6% |
0.6% |
9.8% |
You may also like the below Video Courses